Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adiuvo Diagnostics is an Indian medical technology company specializing in AI-powered opto-electronic diagnostic devices for rapid disease detection. The company's flagship platform, Illuminate, utilizes multispectral autofluorescence imaging and machine learning to detect and classify pathogens on wounds in under two minutes, replacing traditional culture methods that take several days. This non-invasive, label-free technology is designed for point-of-care use, particularly in low-resource settings, to assist in the management of diabetic foot ulcers and skin infections. Adiuvo is also expanding its technology pipeline to include rapid antibiotic susceptibility testing, tuberculosis screening, and cervical cancer diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adiuvo Diagnostics.